Rarely has the entire world been so focused on germs. They have always been everywhere around us, but now, more than ever, we need more effective, more convenient protection for ourselves, our families and our environments. Every new surface we touch throughout our day potentially poses an invisible danger.
One of the most effective ways to avoid spreading germs is to wash your hands thoroughly and regularly with soap and water. To double down on germs and support routine hand washing, Crystawash® 24 Foaming Hand Sanitiser provides peace-of-mind with long-lasting germ protection between hand washes.
Crystawash® 24 is a new generation foaming hand sanitiser that provides effective protection from germ-infected surfaces, killing 99.99% of harmful germs1 on contact and has been shown to keep on killing for up to 24-hours2.
Combining an active antimicrobial agent with a synergistic coating agent allows Crystawash® 24 to effectively bond to skin, creating an invisible, water-proof layer that provides 24-hour2 residual efficacy against harmful germs. The antimicrobial agent kills pathogens by puncturing their cell membranes and essentially rendering them useless, while the coating agent holds it onto the skin to provide prolonged protection.
The long-lasting, gentle protection of Crystawash® 24 offers real advantages over many other sanitisers. Alcohol-based hand sanitisers provide short-term germ protection, and to be effective require reapplication every time a new surface is touched. They also contain up to 70% alcohol, which tends to strip the skin of natural oils, leaving hands dry and chapped and prone to further contamination. Crystawash® 24 is water-based and contains no alcohol or harsh chemicals so will not leave the skin feeling irritated, dry or chapped.
Crystawash® 24 comes in a convenient 50mL purse pack or 500mL family pack and
is available now through AFT Pharmaceuticals at:
P. 1800 AFT PHARM | F. 1800 041 026 | www.aftpharm.com |firstname.lastname@example.org
Learn more at: www.crystawash24.com
References: 1. Eurofins BioPharma Product Testing, Australia; Protocol: TMD-110, EN 13727. 2. 24-hour residual efficacy against germs: AFT Pharmaceuticals/AsureQuality Laboratory Services, New Zealand microbiological effectiveness study on skin. For external use only. For external use only. Avoid contact with eyes. Always read the label. Follow the directions for use. AFT Pharmaceuticals Pty Ltd, Sydney | Patent pending AU2021200502